In hepatocellular carcinoma (HCC), ANXA2 overexpression correlates with tumor aggressiveness and metastasis, influencing cancer progression by regulating the extracellular matrix and promoting tumor cell migration and invasion (49, 50). Here, ANXA2 is linked to hepatocellular carcinoma.